The data from the study was recently published in the peer-reviewed Biological Psychiatry.
Researchers at the University Hospital Basel (UHB) conducted the investigator-initiated study, which involved 42 patients.
While there was a substantial amount of research on LSD-assisted therapy in the 1950s and 1960s, psilocybin has emerged as a more popular compound for psychedelic-based therapy in recent years.
In the data published in Biological Psychiatry, researchers used Spielberger’s State-Trait Anxiety Inventory–Global (STAI-G) score and the HAM-D-21 (Hamilton Depression Rating Scale) to quantify anxiety and depression, respectively. Investigators also used the Beck Depressio…